Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$117.80−1.29 (-1.08%)
Close on Nov 18, 2026Market cap $24.01BP/E 62.7Yield –
Incyte operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Incyte's operating cash flow for the twelve months ending Sep 30, 2026 was $744.99M, down 40.5% year over year. For fiscal 2025 it was $1.41B, up 321.5% from the year before. Over ten years it grew 31.8% a year on average. The highest annual figure on record is $1.41B in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.41B | +321.5% |
| FY2024 | Dec 31, 2024 | $335.34M | -32.5% |
| FY2023 | Dec 31, 2023 | $496.49M | -48.8% |
| FY2022 | Dec 31, 2022 | $969.94M | +29.4% |
| FY2021 | Dec 31, 2021 | $749.49M | – |
| FY2020 | Dec 31, 2020 | -$124.60M | -117.5% |
| FY2019 | Dec 31, 2019 | $710.66M | +111.4% |
| FY2018 | Dec 31, 2018 | $336.23M | – |
| FY2017 | Dec 31, 2017 | -$92.99M | -130.5% |
| FY2016 | Dec 31, 2016 | $304.76M | +240.9% |
| FY2015 | Dec 31, 2015 | $89.41M | +240.5% |
| FY2014 | Dec 31, 2014 | $26.26M | +186.0% |
| FY2013 | Dec 31, 2013 | $9.18M | – |
| FY2012 | Dec 31, 2012 | -$94.83M | – |
| FY2011 | Dec 31, 2011 | -$161.72M | -265.1% |
| FY2010 | Dec 31, 2010 | $97.94M | +692.5% |
| FY2009 | Dec 31, 2009 | $12.36M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$675.32M | -220.7% |
| Q2 FY2026 | Jun 30, 2026 | $507.66M | +1034.7% |
| Q1 FY2026 | Mar 31, 2026 | $369.35M | +38.8% |
| Q4 FY2025 | Dec 31, 2025 | $543.30M | +42.5% |
| Q3 FY2025 | Sep 30, 2025 | $559.39M | +79.9% |
| Q2 FY2025 | Jun 30, 2025 | $44.74M | – |
| Q1 FY2025 | Mar 31, 2025 | $266.07M | +21.6% |
| Q4 FY2024 | Dec 31, 2024 | $381.22M | +158.1% |
| Q3 FY2024 | Sep 30, 2024 | $310.87M | +110.3% |
| Q2 FY2024 | Jun 30, 2024 | -$575.56M | -287.8% |
| Q1 FY2024 | Mar 31, 2024 | $218.81M | – |
| Q4 FY2023 | Dec 31, 2023 | $147.73M | -47.9% |
| Q3 FY2023 | Sep 30, 2023 | $147.84M | -50.1% |
| Q2 FY2023 | Jun 30, 2023 | $306.53M | +76.0% |
| Q1 FY2023 | Mar 31, 2023 | -$105.60M | -148.9% |
| Q4 FY2022 | Dec 31, 2022 | $283.66M | +145.9% |
| Q3 FY2022 | Sep 30, 2022 | $296.38M | +16.2% |
| Q2 FY2022 | Jun 30, 2022 | $174.16M | +0.7% |
| Q1 FY2022 | Mar 31, 2022 | $215.74M | +4.7% |
| Q4 FY2021 | Dec 31, 2021 | $115.35M | +7.5% |
| Q3 FY2021 | Sep 30, 2021 | $255.10M | +40.1% |
| Q2 FY2021 | Jun 30, 2021 | $172.94M | -35.8% |
| Q1 FY2021 | Mar 31, 2021 | $206.10M | – |
| Q4 FY2020 | Dec 31, 2020 | $107.32M | -18.5% |
| Q3 FY2020 | Sep 30, 2020 | $182.12M | -32.7% |
| Q2 FY2020 | Jun 30, 2020 | $269.38M | +76.1% |
| Q1 FY2020 | Mar 31, 2020 | -$683.42M | -539.0% |
| Q4 FY2019 | Dec 31, 2019 | $131.62M | +57.0% |
| Q3 FY2019 | Sep 30, 2019 | $270.42M | +35.8% |
| Q2 FY2019 | Jun 30, 2019 | $152.96M | +372.1% |
| Q1 FY2019 | Mar 31, 2019 | $155.66M | +647.0% |
| Q4 FY2018 | Dec 31, 2018 | $83.84M | – |
| Q3 FY2018 | Sep 30, 2018 | $199.15M | +274.9% |
| Q2 FY2018 | Jun 30, 2018 | $32.40M | -72.3% |
| Q1 FY2018 | Mar 31, 2018 | $20.84M | – |
| Q4 FY2017 | Dec 31, 2017 | -$89.27M | -194.6% |
| Q3 FY2017 | Sep 30, 2017 | $53.12M | – |
| Q2 FY2017 | Jun 30, 2017 | $116.79M | – |
| Q1 FY2017 | Mar 31, 2017 | -$173.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $94.38M | – |
See a number that looks wrong?